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 Cancer risk information had no effect on computed risk or self-reported behaviour  
 There was also no effect on anxiety or cancer related worry 
 Accuracy and conviction of absolute risk perception increased in the short-term 







Few trial data are available concerning the impact of personalised cancer risk information on 
behaviour. This study assessed the short-term effects of providing personalised cancer risk 
information on cancer risk beliefs and self-reported behaviour. We randomised 1018 
participants, recruited through the online platform Prolific, to either a control group receiving 
cancer-specific lifestyle advice or one of three intervention groups receiving their computed 
10-year risk of developing one of the five most common preventable cancers either as a bar 
chart, a pictograph or a qualitative scale alongside the same lifestyle advice. The primary 
outcome was change from baseline in computed risk relative to an individual with a 
recommended lifestyle (RRI)1 at three months. Secondary outcomes included: health-related 
behaviours, risk perception, anxiety, worry, intention to change behaviour, and a newly 
defined concept, risk conviction. After three months there were no between-group differences 
in change in RRI (p=0.71). At immediate follow-up, accuracy of absolute risk perception 
(p<0.001), absolute and comparative risk conviction (p<0.001) and intention to increase fruit 
and vegetables (p=0.026) and decrease processed meat (p=0.033) were higher in all 
intervention groups relative to the control group. The increases in accuracy and conviction 
were only seen in individuals with high numeracy and low baseline conviction, respectively. 
These findings suggest that personalised cancer risk information alongside lifestyle advice 
can increase short-term risk accuracy and conviction without increasing worry or anxiety but 
has little impact on health-related behaviour.  
 
Trial registration: ISRCTN17450583. Registered 30 January 2018. 
 





                                                     




Approximately 40% of cancer cases can be attributed to lifestyle factors such as smoking, 
alcohol intake, diet, physical activity levels and sun protection(1).  Encouraging individuals 
to adopt healthy lifestyles offers a potentially cost-effective, long-term approach to cancer 
control.  
 
One strategy for targeting individuals is providing personalised information about risk. While 
evidence for behaviour change in other disease areas following the provision of personalised 
risk information is limited(2), the impact of cancer risk provision on behaviour is not 
known(3) and. there are reasons to believe that the impact of provision of information about 
risk of cancer might differ. People are more concerned about developing and dying from 
cancer than from cardiovascular disease(4,5) and a high proportion of individuals incorrectly 
believe their cancer risk to be higher than current estimates. There is also a lack of awareness 
of the role lifestyle plays in the development of cancer(6) and a significant minority of the 
public continue to believe that cancer risk is unmodifiable(7). Although originally developed 
to understand responses to fear appeals, two widely used theories of behaviour change(8,9), 
can help describe how such overestimation and lack of response efficacy, or the perceived 
effectiveness of recommended actions, might be associated with maladaptive responses such 
as feelings of fatalism or hopelessness(10–12) and decreased motivation to change behaviour. 
For example, individuals who overestimate their risk of developing cancer and are unaware 
of the benefits of changes in their lifestyle, may feel it is almost useless to try to stay healthy 
and so have low motivation to change. When accompanied by information about these risk 
factors and the benefits of change, personalised cancer risk information may therefore 
improve the accuracy of risk perception and reduce overestimation and increase response 
efficacy, in turn  reducing maladaptive responses and motivating behaviour change (Figure 
1). 
 
An important element of risk communication that influences accuracy of risk perception 
(hereafter referred to as risk accuracy) and may also have an impact on other risk beliefs and 
subsequent behaviour change is the format in which risk is presented(13–16).  
Risk conviction, a newly defined concept which represents “the subjective sense that one 
knows what one’s risk belief is and confidence that this risk belief is accurate”(17), may also 
influence subsequent behaviour change by influencing the relationship between risk 
perception and behaviour.. Previous research has shown that uncertainty about perceived risk 
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is associated with lower odds of change in self-report dietary and physical activity 
measures(18,19) and that attitudes held with greater certainty are more stable and persistent 
and may have a stronger influence on behaviour(20). However, no studies have measured risk 
conviction after provision of risk information and it is not known whether risk conviction can 
be altered.   
 
In a parallel-group randomised controlled trial we therefore aimed to assess the short-term 
effects on health-related behaviours and risk beliefs, including risk perception and risk 
conviction, of three different formats (a bar chart, pictograph and qualitative scale) of 
personalised cancer risk information alongside lifestyle advice. We hypothesised that there 
would be a reduction in computed relative risk in the three risk groups combined when 
compared with the control group, there would be no difference between the two numerical 
presentations (bar chart and pictographs) and there would be greater reductions in computed 
relative risk in the qualitative group than the groups presented with numerical information. 
We further hypothesised that there would be increases in absolute and comparative risk 
accuracy and conviction in the three risk groups combined compared with the control group 
and greater increases in absolute accuracy and conviction in the numerical groups than the 
qualitative group.  
 
METHODS 
The study is reported in accordance with the CONSORT guidelines(21). Full details of the 
design and methods of the study are published elsewhere(22). Briefly, this was a web-based 
parallel-group, open randomised control trial with a control group that received cancer-
specific lifestyle advice and three intervention groups that received  their computed 10-year 




1018 participants were recruited between 10-12 April 2018 using Prolific Academic 
(https://www.prolific.ac/). Eligible individuals were men and women aged 30-74 years, 
resident in the UK, without a past history of cancer and with a Prolific approval rating 
(reflecting the proportion of studies completed to the standard accepted by researchers) ≥ 
95%(23). Participants received a small financial reward (£3) for taking part.  Participants 
were randomised 1:1:1:1 to four groups at an individual level based on computer generated 
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random numbers within block sizes of eight. Randomisation was stratified by sex, risk 
relative to an individual with a recommended lifestyle (≤ or > 1.5) and age (≤ or > 40 years).  
 
To identify inattentive participants and increase the reliability and validity of responses(24), 
an instructional manipulation check (“It is important that you pay attention in this study. 
Please tick ‘strongly disagree’”) was included in the baseline questionnaire. Participants who 
failed this check or who failed to provide sufficient information for the calculation of a risk 
estimate were excluded prior to randomisation.  
 
Computed risk and the interventions 
It was not possible to blind participants to which intervention they received. Participants in 
all groups were provided with lifestyle advice on six target behaviours: smoking cessation, 
weight loss, reduction of alcohol consumption, increasing fruit and vegetable consumption, 
decreasing red and processed meat consumption and increasing physical activity. The three 
intervention groups additionally saw their computed 10-year risk of developing one of the 
five commonest preventable cancers (lung, colorectal, bladder, kidney and oesophageal for 
men and breast, lung, colorectal, endometrial and kidney for women). This risk was 
computed using a lifestyle-based risk score developed for this purpose(25). In brief, lifestyle 
factors for each cancer were selected from the European Code against Cancer and estimates 
of the relative risks from meta-analyses of observational studies. Average population values 
for each risk factor were then used to calculate estimates of 10-year risk of developing one or 
more of the given cancers. In men the risk model showed good discrimination (AUC: 0.71, 
95%CI 0.69-0.73) and calibration. Discrimination was lower in women (AUC: 0.59,0.57–
0.61) but calibration was good. Participants were presented with the estimated 10-year risk in 
one of the three formats (Figure 2). Further information about the risk scores was also 
provided (Supplementary File 1) and the participant information sheet included details of 
organisations for further information and support (Supplementary File 2). Participants in all 
three groups were able to set target values for each of the target behaviours and see the effect 
of this on their risk.  
 
Measures 
To enable us to assess the impact on behaviour change independent of age and sex, the 
primary outcome was change from baseline to three months in computed risk relative to an 
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individual of the same age and sex with a recommended lifestyle (RRI). Full details of the 
secondary outcomes are in the published protocol(22) and Supplementary Table S1.  
   
Statistical analyses 
All analyses were performed based on the intent-to-treat principle.   
 
Primary outcome 
We used analysis of covariance to calculate change in RRI at three-month follow-up. Any 
difference between the four randomised groups was tested using an F test, followed by 
estimation of four pairwise contrasts between the study groups: 1) Control group vs the three 
risk groups combined; 2) bar chart presentation vs pictographs; 3) bar chart presentation vs 
qualitative scale; and 4) pictographs vs qualitative scale. An F test was used to test for 
interactions between the groups and: age (≤40/> 40 years), sex (to assess for differences due 
to variable effects of lifestyle change across the cancers included in the sex specific risk 
models), baseline RRI (≤1.5/> 1.5), self-perceived risk at baseline below or above computed 
risk and numeracy (<2/≥2). Analyses were repeated within the subgroups where the p-value 
for interaction was <0.05.  
 
Secondary outcomes, acceptability and process measures 
We used the same approach for continuous secondary outcome variables (awareness of 
cancer risk factors, risk conviction, maladaptive coping, anxiety, cancer worry, BMI, physical 
activity and diet and alcohol). Logistic regression (adjusted for baseline) was used to analyse 
binary secondary outcome variables (absolute and comparative risk accuracy and smoking 
status). Absolute risk accuracy was defined as a difference of 5% or less between computed 
and perceived absolute risk, with sensitivity analyses using ±1% and ±10% limits performed 
due to the heterogeneity of the definition of risk accuracy in the literature(14,15,26). 
Comparative risk accuracy was defined as agreement between computed and perceived 
comparative risk on a continuous seven-point scale from “Much lower” to “Much higher”. A 
sensitivity analysis defining average comparative risk perception as responses between 3 and 
5 on the scale was also performed. Linear regression was used to analyse intention to change 
behaviour, self-efficacy and response efficacy (all considered as continuous variables) 
because these outcomes were measured only at immediate follow up. As there was high 
correlation (r>0.8) between the two questions used to measure risk conviction, the responses 




As risk perception has been demonstrated to be influenced by age, sex, numeracy and 
whether individuals over or underestimate their risk at baseline(26–28), we also planned a 
priori to explore the impact of these factors on risk accuracy and risk conviction. We did this 
by including age (<40 years/≥40 years), sex, numeracy (<2/≥2), baseline risk accuracy 
(underestimate/accurate/overestimate) and baseline risk conviction (<4/ ≥4 ) as categorical 
interaction terms within the logistic regression or ANCOVA models detailed above. Where 
there was evidence against the null (p<0.05) for any of these interactions the variables are 
summarised separately.  
 
Confidence intervals (98.75%, based on a Bonferroni corrected significance threshold of 
1.25%) are presented for all outcomes to acknowledge that four pairwise comparisons were 
performed. All analyses were performed using STATA V.15.1.  
 
Sample size 
Based on the mean (1.77) and standard deviation (0.97) of the computed risk of developing 
one or more of the five chosen cancers relative to an individual with a recommended lifestyle 
in the EPIC-Norfolk cohort used for external validation of the risk scores(29), and assuming a 
10% loss to follow-up, we estimated that with 1000 participants (250 per group) we could 
detect a baseline-adjusted between-group difference of 0.3, with 98.75% confidence and 79-
83% power (depending on the degree of correlation between baseline and follow up values). 
 
Post-hoc analyses 
To investigate the impact of provision of risk information amongst those who engaged with 
the lifestyle advice, we performed post-hoc analyses including only those participants who 




1163 individuals completed the online consent form. Of these, 145 were excluded prior to 
randomisation. 863 of the 1018 who were randomised completed the three-month follow up 
questionnaire (85% retention) (Figure 3). Table 1 summarises the baseline characteristics of 
participants in each group. Characteristics were similar across the groups. The mean age of 
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participants was 43.9 years (SD 10.0). 49% were aged between 30 and 40 years. Females 
made up 71% of the cohort and 93% were White Caucasian.  
 
The median perceived absolute risk across the four groups was 25% (IQR 10-50%). The 
median computed absolute risk of the study population was only 0.83% (IQR 0.53-2.63%). 
The vast majority of participants (81%) were therefore overestimating their risk at baseline. 
This included almost a fifth of participants who reported perceived absolute cancer risk of 
50% at baseline (18%) and at immediate (16%) and three-month (21%) follow up. The 
median concern about developing cancer was 5 (IQR 3-6), with over half (52%) 
“Moderately”, “Very” or “Extremely” concerned. The median computed risk relative to an 
average individual of the same age and sex (RR) was 1 (IQR 0.8-1.2) and the median 
computed risk relative to an individual of the same age and sex with a recommended lifestyle 
(RRI) was 1.2 (IQR 1-1.6). 
 
Median baseline absolute and comparative risk conviction were 2.5 (IQR 1.5-4) and 3 (IQR 
2-4.5) respectively across the study groups. The majority of participants (>75%) reported 
baseline conviction scores at or below 4 (the midpoint of the scale), suggesting relatively low 
certainty and confidence in their risk perceptions. 
 
Primary Outcome 
Tables 2 and 3 shows means and SDs for primary and secondary outcomes at baseline and 
change from baseline. Details of the four pairwise comparisons are presented in Figures 4 and 
5 and in Supplementary Tables S2 and S3.  
 
There was no evidence of differences in change from baseline RRI between the randomised 
groups at three-month follow up (p=0.711). There was a significant interaction with baseline 
RRI (p<0.001) but no interactions between the interventions and age (p=0.183), sex 




At immediate follow-up there were significant increases in absolute and comparative risk 
conviction, response efficacy, intention to consume more fruit and vegetables, intention to 
reduce processed meat consumption and absolute risk accuracy in the three intervention 
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groups combined compared with the lifestyle only group (Figure 4 and Table 2). Consistent 
with the fact that those in the qualitative group did not receive numbers relating to their 
absolute risk, there were also increases in absolute risk conviction and absolute risk accuracy 
in the bar chart group compared with the qualitative group, absolute risk conviction in the 
pictograph group compared with the qualitative group and absolute risk accuracy in the bar 
chart group compared with the qualitative group.  
 
For both absolute and comparative risk conviction there was a significant interaction with 
baseline risk conviction (p=0.002 and p=0.007 respectively), such that the increases in risk 
conviction emerged only among those with low baseline conviction. There was also a 
significant interaction with baseline risk conviction for comparative risk accuracy (p=0.003), 
such that increases in comparative risk accuracy observed in the intervention groups relative 
to the control and the pictograph group relative to  the bar chart group appeared only in those 
with high baseline risk conviction. For absolute risk accuracy there were interactions with 
both numeracy (p=0.009) and whether the participants were accurate at baseline (p=0.001). 
No differences were seen in those with low numeracy or who were accurate at baseline. For 
those with high numeracy or who overestimated their risk at baseline all four comparisons 
were significant. There were no interactions with age or sex. 
 
At 3-month follow-up there was a significant difference in comparative risk accuracy 
between the four groups, with an increase in accuracy in the pictograph group compared with 
the qualitative scale group. As at immediate follow-up, there was a significant interaction 
with baseline risk conviction (p=0.002), with the increase only observed in those with low 
baseline risk conviction. There was also a significant interaction for comparative risk 
accuracy with numeracy (p=0.036) and for absolute risk accuracy with baseline risk 
conviction (p=0.037), but no between group differences. There were no other between-group 
differences in any of the measured outcomes (Figure 5 and Table 3). No differences were 
seen in sensitivity analyses using different thresholds to define accuracy.  
 
Acceptability and process measures 
The acceptability of the cancer-specific lifestyle advice was good with the majority of 
participants finding it understandable (84%), trustworthy (75%), useful (77%), motivating 
(67%), important (74%) and well presented (78%) (Supplementary Table S4). The 




Of the six cancer-specific lifestyle advice pages with which participants were provided, 60% 
did not view any and only 21% viewed three or more (Supplementary Table S5). There was 
no significant difference (p=0.379) in the number of lifestyle pages viewed across the four 
groups and no significant differences in intention or behaviour between the groups in the post 
hoc analysis including only the participants who had viewed one or more lifestyle advice 
pages (Supplementary Tables S6 and S7). The control group spent on average 46 seconds(s) 
(IQR 30s-1m 35s) viewing the lifestyle information pages. This compares with an average 2 
minutes(m) 24 seconds(s) (IQR 1m 34s-3m 47s) the intervention groups spent interacting 
with the intervention and viewing the same risk pages (Supplementary Table S5).  
 
DISCUSSION 
Our findings suggest that the provision of personalised cancer risk information alongside 
lifestyle advice can increase short term risk accuracy, conviction about one’s risk, and 
intention to change behaviour more than lifestyle advice alone.  It appears to do so without 
increasing cancer related worry or anxiety yet has little impact on health-related behaviour. 
Our results also suggest that the impact of risk communication on risk perception may be 
dependent on format and recipients’ numeracy and the conviction with which they believe 
their initial perceived risk.  
 
Similar increases in short term risk accuracy have been demonstrated previously(30). Of the 
13 studies identified in that review, however, only one reported risk accuracy at two time 
points(31) and only two compared provision of absolute and comparative risk 
estimates(32,33). Our findings that the increases in absolute risk accuracy immediately after 
the intervention were only amongst those with high numeracy and those who overestimated 
their risk at baseline, and did not persist at three months highlight the challenges associated 
with changing individuals’ perceptions of their own risk and the potential for risk information 
to widen inequalities. To our knowledge, this is not only the first study to measure change in 
multiple behaviours following provision of personalised cancer risk information but is also 
the first study to explore the effect of risk communication on risk conviction and the 
association between  risk conviction and risk accuracy. Our findings suggest that risk 
conviction, as measured in this study, is distinct from risk perception. Moreover, accuracy of 
perceived risk after risk information appears to be moderated by risk conviction. Importantly, 
we also showed that risk conviction increased within the intervention groups, demonstrating 
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that risk conviction can be manipulated. Those differences were only observed in those with 
low baseline risk conviction, however, suggesting that changing risk conviction is more 
difficult in those who already have strong beliefs about their risk. These differences were not 
present at three months, suggesting that changes in risk conviction may not persist.  
 
The observed increase in intention to consume more fruit and vegetables and reduce 
processed meat consumption amongst participants in the intervention groups suggests that 
provision of risk information may have short-term beneficial effects over and above lifestyle 
information alone. These differences were, however, small and were not associated with 
health-behaviour change. This lack of behaviour change may reflect the low levels of 
engagement with the lifestyle advice components but is also consistent with previous studies 
(34) and the well-reported gap between intention and behaviour change(3,35).  
 
It is also possible that participants did not understand the risk estimates or the meaning of 
cancer risk: a substantial proportion reported perceived absolute cancer risk of 50% both 
before and after the intervention, potentially reflecting uncertainty(36).  
 
Additionally, as we hypothesised and is seen in previous studies(30,33), the majority (81%) 
of participants over-estimated their absolute cancer risk at baseline. As well as potentially 
reducing maladaptive behaviours, conceivably the risk information could have reassured 
participants, leading to the adoption of unhealthy behaviours. Our results show no evidence 
of this. They additionally support existing evidence that provision of disease risk does not 
increase disease-specific worry or general anxiety(38–40).   
 
Strengths and limitations 
Our study benefits from several key strengths. These include the randomised control trial 
design, the large sample size and the high retention at three-month follow-up.    
 
However, we acknowledge some weaknesses. In particular, using an online platform enabled 
recruitment of a large sample size but limited external validity: the demographics of Prolific 
members are not necessarily representative of the UK population(41). We were, however, 
able to recruit a population with a range of ages and educational attainment. The median 
computed risk relative to an average individual of the same age and sex was 1 (IQR 0.8-1.2), 
indicating that most participants had a computed 10-year cancer risk comparable to that of an 
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average individual of their age and sex in England. The observed changes in risk accuracy are 
also consistent with our prior hypotheses, suggesting that participants in the intervention 
groups engaged with the risk information. Nevertheless,  the same findings may not emerge if 
cancer risk information were provided as part of routine clinical practice. Most of our 
population were also concerned about developing cancer at baseline. The response to risk 
information may vary depending on that a priori awareness of the health threat in other 
populations. The use of self-report measures of behaviour also introduces the risk of both 
social desirability and recall bias. Less than half of the participants engaged with the lifestyle 
advice component and we do not know how the presentation of the combined risk of one or 
more of the cancers was interpreted by participants. The findings relating to risk conviction 
are also based on two recently developed questions to measure risk conviction. Further 
research is needed to assess the validity of those questions. 
 
Conclusion 
This trial shows that provision of personalised cancer risk information alongside lifestyle 
advice increases risk accuracy, risk conviction and intention to change behaviour 
immediately without increasing anxiety or worry but there is no evidence that the information 
motivates health behaviour change. It additionally provides some indication of the more 
effective formats of risk presentation but suggests that their impact is dependent on numeracy 
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Figure 1. Proposed theoretical mechanism for intervention. 
Figure 2. Risk presentation formats. (a) Bar chart; (b) 100 icon pictograph for those with an 
absolute risk >8%; (c) 1000 icon pictograph with a magnified section of 100 icons for those 
with a relative risk  ≤8%; (d) qualitative scale.   Reproduced with permission from Usher-
Smith JA et al. BMC Public Health 18(1):796. doi: 10.1186/s12889-018-5712-2 
Figure 3. Consort flow diagram 
Figure 4. Pairwise analyses results for a) each continuous secondary outcome measure and b) 
each categorical secondary outcome measure at immediate follow up 
Figure 5. Pairwise analyses results for a) each continuous secondary outcome measure and b) 
each categorical secondary outcome measure at 3 month follow up. RRI – risk relative to an 
individual of the same age and sex with a recommended lifestyle  
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Table 1. Baseline characteristics of participants 
  
Group 1: Lifestyle advice  
(N =253) 
Group 2: Bar charts 
(N = 252) 
Group 3: Pictographs  
(N = 255) 
Group 4: Qualitative  
(N = 257)  
n Mean (SD) / % (n) n Mean (SD) / % (n) n Mean (SD) / % (n) n Mean (SD) / % (n) 
Age (yrs)  253 42.4 (9.0) 252 43.4 (10.4) 255 42.7 (10.0) 257 43.0 (10.4) 



































Sex (% female) 253 71.2 (180) 252 71.8 (181) 255 71.0 (181) 257 71.6 (184) 
Ethnicity (% white) 253 94.5 (239) 250 92.8 (232) 254 92.9 (236) 255 93.3 (238) 
Family history cancer (% yes)  251 35.5 (89) 249 35.3 (88) 253 38.3 (97) 253 40.7 (103) 
Estimated risk*         
   Absolute (%)** 253 0.8 (0.5-2.5) 252 0.8 (0.5-3.1) 255 0.8 (0.5-2.7) 257 0.9 (0.5-2.5) 
   Relative to individual of same age and sex** 253 1.0 (0.9-1.2) 252 1.0 (0.9-1.2) 255 1.0 (0.8-1.2) 257 1.0 (0.8-1.2) 
   Relative to individual of the same age and  
   sex with a recommended lifestyle** 
253 1.3 (1.0-1.6) 252 1.3 (1.0-1.6) 255 1.2 (1.0-1.6) 257 1.2 (1.0-1.6) 
Risk perception  
       
   Absolute (%)** 223 25 (10-50) 227 20 (10-50) 224 25 (10-50) 236 30 (10-50) 
   Comparative (relative to individual of the  
   same age and sex) (range 1-7)** 
253 4 (3-5) 252 4 (3-5) 255 4 (3-4) 257 4 (3-5) 






































































Risk conviction (range 0-7) 
        
   Absolute** 246 3.0 (1.5-4.0) 250 3.0 (1.5-4.5) 252 2.5 (1.5-4.0) 256 2.5 (1.5-4.0) 
   Comparative** 243 3.0 (2.0-4.5) 245 3.0 (2.0-5.0) 248 3.0 (2.0-4.0) 245 3.0 (2.0-4.0) 
Numeracy  253  251  254  255  
  High (≥2)  72.7 (184)  73.3 (184)  74.4 (189)  75.3 (192) 
  Low (<2)  27.3 (69)  26.7 (67)  25.6 (65)  24.7 (63) 
Concern about developing cancer (range 0-7)** 249 5 (3-6) 250 5 (3-6) 252 5 (3-6) 257 5 (3-6) 
* All risk estimates represent the 10 year risk of developing one of the five most common, gender specific, preventable cancers 
** Median (IQR) 
Table 2. Means and SDs of baseline and change from baseline to immediate follow-up values 
 Group 1: Lifestyle advice  Group 2: Bar charts Group 3: Pictographs  Group 4: Qualitative  
















n Mean (SD) Mean 
(SD) 
n Mean (SD) Mean (SD) n Mean 
(SD) 
Mean 
(SD) Secondary continuous outcomes 
            
Awareness of cancer risk factors 238 40.0 (5.6) 2.9 (4.2) 241 40.9 (5.0) 3.4 (3.9) 237 40.3 (5.7) 3.7 (4.3) 242 40.7 (5.6) 3.3 (4.3) 
Risk conviction             
    Absolute 247 2.9 (1.5) 0.16 (1.1) 250 3.0 (1.7) 0.48 (1.5) 253 2.9 (1.6) 0.74 (1.6) 256 2.9 (1.5) 0.26 (1.1) 
    Comparative 243 3.2 (1.5) -0.01 (1.0) 245 3.3 (1.6) 0.38 (1.4) 249 3.2 (1.5) 0.40 (1.3) 245 3.2 (1.5) 0.32 (1.3) 
Self-efficacy 229 --- 21.6 (4.6) 236 --- 22.1 (4.3) 242 --- 22.1 (4.3) 246 --- 22.3 (4.1) 
Response efficacy 229 --- 22.9 (4.0) 240 --- 23.8 (4.1) 236 --- 24.0 (4.3) 233 --- 23.8 (4.5) 
Maladaptive coping 250 9.2 (2.1) -0.12 (1.6) 249 9.3 (2.0) -0.32 (1.6) 255 9.4 (2.0) -0.35 (1.6) 256 9.2 (2.1) -0.26 (1.5) 
Anxiety (SF-SSAI) 242 12.0 (4.2) 0.37 (2.0) 245 12.2 (4.4) 0.21 (2.3) 252 12.3 (4.3) 0.17 (2.1) 246 12.0 (3.9) 0.13 (1.9) 
Intention to change behaviour             
General 238 --- 21.9 (4.2) 241 --- 22.1 (4.6) 243 --- 22.0 (4.6) 246 --- 21.8 (4.5) 
Weight 214 --- 3.9 (1.0) 218 --- 4.0 (1.0) 212 --- 3.9 (1.0) 216 --- 3.9 (1.0) 
Alcohol 183 --- 3.6 (1.1) 182 --- 3.7 (1.1) 198 --- 3.6 (1.0) 173 --- 3.4 (1.1) 
Physical activity 242 --- 5.4 (12.2) 244 --- 5.1 (10.5) 249 --- 5.8 (13.4) 251 --- 5.4 (12.0) 
Fruit and veg 240 --- 3.8 (0.8) 241 --- 4.0 (0.8) 247 --- 3.9 (0.8) 244 --- 4.0 (0.7) 
Red meat 208 --- 3.2 (1.0) 204 --- 3.4 (1.1) 214 --- 3.3 (1.1) 206 --- 3.4 (1.0) 
Processed meat 209 --- 3.5 (1.0) 211 --- 3.7 (1.1) 206 --- 3.7 (1.0) 206 --- 3.7 (1.0) 
Quit smoking 68 --- 3.5 (1.0) 60 --- 3.8 (1.1) 73 --- 3.8 (1.0) 65 --- 3.7 (1.1)  
n % (n) % n % (n) % n % (n) % n % (n) % 
Secondary categorical outcomes 
            
Risk accuracy             
    Absolute 223 19 (42) -3.0 227 21 (47) 6.5 225 19 (42) 30.1 236 18 (42) -2.4 
        Low numeracy 62 18 (11) -3.6 59 17 (10) -1.9 57 26 (15) 10.4 56 16 (9) 0 
        High numeracy 161 19 (31) -2.8 167 22 (37) 9.7 168 16 (27) 36.0 178 19 (33) -3.1 
    Comparative 253 37 (94) 1.7 252 40 (100) 0.4 256 43 (110) -10.8 257 41 (106) -4.8 
 
* Change from baseline was calculated as follow-up minus baseline. Immediate follow-up values given for those variables not measured at baseline.  
 
Table 3. Means and SDs of baseline and change from baseline to 3 month follow-up values 
 Group 1: Lifestyle advice  Group 2: Bar charts Group 3: Pictographs  Group 4: Qualitative  












 n Mean 
(SD) 
Mean (SD) n Mean (SD) Mean (SD) n Mean 
(SD) 
Mean (SD) n Mean 
(SD) 
Mean (SD) 
Primary outcome             
Risk relative to individual of the 
same age and sex with a 
recommended lifestyle 
253 1.5 (0.8) -0.0001 (0.6) 252 1.6 (1.1) -0.07 (0.9) 256 1.5 (0.8) 0.007 (0.4) 257 1.5 (0.8) 0.003 (0.4) 
             
Secondary continuous outcomes             
Awareness of cancer risk factors 238 40.0 (5.6) -1.6 (4.5) 241 40.9 (5.0) -2.2 (4.3) 237 40.3 (5.7) -1.9 (4.6) 242 40.7 (5.6) -2.2 (4.5) 
Risk conviction             
    Absolute 247 2.9 (1.5) 0.06 (1.8) 250 3.0 (1.7) -0.17 (1.5) 253 2.9 (1.6) -0.47 (1.7) 256 2.9 (1.5) 0.10 (1.5) 
    Comparative 243 3.2 (1.5) 0.19 (1.5) 245 3.3 (1.6) -0.09 (1.6) 249 3.2 (1.5) -0.14 (1.4) 245 3.2 (1.5) 0.03 (1.6) 
Maladaptive coping 250 9.2 (2.1) 0.25 (1.9) 249 9.3 (2.0) 0.51 (1.9) 255 9.4 (2.0) 0.32 (1.8) 256 9.2 (2.1) 0.16 (1.9) 
Anxiety (SF-SSAI) 242 12.0 (4.2) -0.60 (3.2) 245 12.2 (4.4) -0.75 (3.7) 252 12.3 (4.3) -0.38 (3.5) 246 12.0 (3.9) -0.42 (3.1) 
Cancer worry 248 5.0 (2.2) -0.06 (2.0) 249 5.4 (2.6) -0.02 (2.0) 252 5.3 (2.6) -0.24 (2.1) 252 5.3 (2.6) -0.01 (1.9) 
Lifestyle             
BMI 253 28.5 (6.7) -0.42 (3.9) 252 28.7 (7.0) -0.17 (3.8) 256 28.2 (7.1) 0.04 (3.7) 257 28.0 (6.8) -0.19 (3.4) 
Alcohol 251 5.9 (9.4) 0.35 (4.6) 250 5.7 (9.0) -0.005 
(4.8) 
254 5.3 (7.8) -0.22 (5.0) 256 5.5 (8.8) 0.23 (3.7) 
Physical activity 243 3.4 (3.1) 0.36 (2.4) 241 3.1 (2.8) 0.66 (2.5) 243 3.2 (3.0) 0.48 (2.4) 245 3.5 (3.2) 0.54 (2.8) 
Fruit and veg 253 2.0 (1.5) 0.23 (1.4) 252 1.9 (1.3) 0.30 (1.4) 256 1.9 (1.4) 0.31 (0.94) 257 1.9 (1.4) 0.27 (0.93) 
Red meat 253 2.1 (1.7) 0.10 (1.5) 251 2.1 (2.0) -0.10 (1.2) 255 1.9 (1.6) 0.15 (1.6) 257 2.0 (1.8) -0.02 (1.5) 
Processed meat 253 2.0 (1.8) -0.06 (1.2) 252 2.0 (2.1) -0.12 (1.4) 256 1.8 (1.7) 0.05 (1.6) 257 1.8 (1.6) -0.08 (1.3)  
n % (n) % n % (n) % n % (n) % n % (n) % 
Secondary categorical outcomes 
            
Current smoker 253 15 (39) 0.5 252 12 (31) 2.8 256 15 (38) 0 257 14 (37) 0.5 
Risk accuracy             
    Absolute 223 19 (42) -6.4 227 21 (47) -10.5 225 19 (42) -1.8 236 18 (42) -4.5 
    Comparative 253 37 (94) 6.3 252 40 (100) -3.3 256 43 (110) 0.5 257 41 (106) -10.4 
 
* Change from baseline was calculated as three month follow-up minus baseline 
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Figure 4a. Pairwise analyses results for each continuous secondary outcome measure at immediate follow up
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Figure 4b. Pairwise analyses results for each categorical secondary outcome measure at immediate follow up
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Figure 5a. Pairwise analyses results for each continuous secondary outcome measure at 3 month follow up. 
RRI – risk relative to an individual of the same age and sex with a recommended lifestyle. 
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Figure 5b. Pairwise analyses results for each categorical secondary outcome measure at 3 month follow up
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